Standout Papers

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults w... 2018 2026 2020 2023 241
  1. FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia (2018)
    Aviva C. Krauss, Xin Gao et al. Clinical Cancer Research

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
2 intermediate papers

Works of Kumar G. Janoria being referenced

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
2018 Standout

Author Peers

Author Last Decade Papers Cites
Kumar G. Janoria 252 218 134 213 12 733
Jayaganesh V. Natarajan 297 173 136 342 9 798
Ruchit Trivedi 213 124 67 165 10 616
Pradeep K. Karla 145 277 107 101 15 640
Omar H. El-Garhy 177 182 88 134 8 591
Nancy L. Boman 395 72 62 322 10 685
Sulabh Patel 250 342 169 203 22 756
Jeh‐Chang Yang 293 313 85 237 9 830
Bharath Raja Guru 279 174 42 210 21 745
Carole Bloquel 387 98 129 41 14 786
Hyounkoo Han 225 87 103 270 20 826

All Works

Loading papers...

Rankless by CCL
2026